Intake of n -3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021
Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021
Intake of antioxidants and n-3 and n-6 PUFA in relation to asthma and eczema in a cohort of pregnant women Source: Eur Respir J 2002; 20: Suppl. 38, 428s Year: 2002
Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001
Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007
Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Prenatal polyunsaturated fatty acid exposure is associated with childhood atopy and wheeze Source: Annual Congress 2010 - Paediatric epidemiology Year: 2010
Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004
Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006
Prenatal exposure to n-6/n-3 fatty acids, trace elements and minerals and risk of atopic disease in childhood: birth cohort study Source: Eur Respir J 2003; 22: Suppl. 45, 564s Year: 2003
The role of partially hydrolysed formulae, probiotics and omega-3 fatty acids in cow‘s milk allergy in children Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009
Polyunsaturated fatty acids in maternal diet and maternal and cord blood in relation to atopic dermatitis in children Source: Eur Respir J 2004; 24: Suppl. 48, 161s Year: 2004
Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
DNA and fatty acids oxidative stress in respiratory diseases: Preliminary results from the GEIRD study Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011
Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Effect of omega-3 and phosphoethanolamine in patients with asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007